| Gerard P Bouchard, RPH | |
|
121 Medical Center Dr, Suite G-500, Brunswick, ME 04011-2653 | |
| (207) 729-3642 | |
| (207) 729-2704 |
| Full Name | Gerard P Bouchard |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 121 Medical Center Dr, Brunswick, Maine |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487773412 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | PR2767 (Maine) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Gerard P Bouchard, RPH 121 Medical Center Drive, Suite G-500, Brunswick, ME 04011 Ph: (207) 729-3642 | Gerard P Bouchard, RPH 121 Medical Center Dr, Suite G-500, Brunswick, ME 04011-2653 Ph: (207) 729-3642 |
News Archive
Amedisys, Inc., one of America's leading home health nursing companies, today reported its financial results for the three-month period ended March 31, 2010. We posted record financial performance with net service revenue and net income attributable to Amedisys, Inc., increasing 20.8% and 35.6%, respectively, over the three-month period ended March 31, 2009.
New research from Uppsala University shows promising progress in the use of anti-inflammatory cytokine for treatment of type 1 diabetes. The study, published in the open access journal Scientific Reports (Nature Publishing Group), reveals that administration of interleukin-35 (a protein made by immune cells) to mice with type 1 diabetes, reverses or cures the disease by maintaining a normal blood glucose level and the immune tolerance.
According to the medical records of 26 children diagnosed with the disease, oral medications reduced levels of a compound in the blood called hemoglobin A1C by an average of 2 percentage points.
A significant percentage of patients undergoing targeted CT of the heart have abnormalities outside the coronary arteries, some of which could be life threatening, and as a result need the experience of trained radiologists to interpret them, say researchers from the University of Michigan Cardiovascular Center in Ann Arbor.
Omeros Corporation, a biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting inflammation, coagulopathies and disorders of the central nervous system, announced today the nationwide commercial availability of Omidria (phenylephrine and ketorolac injection) 1%/0.3%.
› Verified 1 days ago
Dr. Peter Michael Nardozzi, RPH, CIP Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10 Brickyard Ct, Signature Pines, Brunswick, ME 04011 Phone: 207-607-4267 | |
Adam Decatur, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 329 Maine St, Brunswick, ME 04011 Phone: 207-373-2235 | |
Logan Renee Newman, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 156 Maine St, Brunswick, ME 04011 Phone: 207-729-8100 Fax: 207-725-1355 | |
Dr. Stephanie Renee Copp, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 156 Maine St, Brunswick, ME 04011 Phone: 207-729-8100 | |
Sarah Ann Manuels, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 147 Bath Rd, Brunswick, ME 04011 Phone: 207-729-8587 | |
Dr. Alejandro A. Enriquez Zamalloa, PHARMD, MS Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 14 Maine St, Suite 208, Brunswick, ME 04011 Phone: 207-907-1612 | |
Mrs. Kristen Beth Austin, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 147 Bath Rd, Brunswick, ME 04011 Phone: 207-721-0900 Fax: 207-721-0662 |